Home › Funds › Point72 Asset Management › SPRO
Point72 Asset Management position in SPRO
SPERO THERAPEUTICS INC · Health Care
Latest position (Q2 2026)104.38K sh
Reported value held$230.67K
Portfolio Weight0.00%
First reportedQ4 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 43.58K | $101.54K | New |
| Q1 2026 | 59.67K | $139.62K | Add |
| Q2 2026 | 104.38K | $230.67K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SPRO
- Vanguard Group 2.08M sh · $4.85M · Q4 2025
- Renaissance Technologies 947.90K sh · $2.09M · Q2 2026
- BlackRock Inc 594.40K sh · $1.31M · Q2 2026
- Geode Capital Management 566.33K sh · $1.25M · Q2 2026
- Two Sigma Investments 382.81K sh · $846.02K · Q2 2026
- Arrowstreet Capital 332.97K sh · $735.86K · Q2 2026
- Goldman Sachs Group 256.99K sh · $567.94K · Q2 2026
- UBS Group AG 139.68K sh · $308.69K · Q2 2026
- Northern Trust Corp 108.27K sh · $239.29K · Q2 2026
- Citadel Advisors 65.60K sh · $144.98K · Q2 2026
- Invesco Ltd 64.25K sh · $141.98K · Q2 2026